The Study
Evaluating the Impact of Omega-3 Fatty Acid (SolowaysTM) Supplementation on Lipid Profiles in Adults with PPARG Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial
This study is like a fair test where half the people got omega-3 pills and half got sugar pills, but only the ones with a special gene got the big benefit. It shows the pills really did lower bad cholesterol in those people—but it doesn’t prove it will stop heart attacks or help everyone.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
Some people have a genetic quirk that makes their body respond better to omega-3 fish oil pills — it lowers their bad cholesterol and fats more than in others.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 569 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — for people with this gene variant, omega-3 pills cut bad fats nearly twice as much as for others, suggesting personalized treatment could work better.
- 2In people with the gene quirk: LDL-C dropped 15.4%, triglycerides dropped 21.3%.
- 3In people without it: LDL-C dropped only 3.7% — same as placebo.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Nutrients
Year
2023
Authors
E. Pokushalov, A. Ponomarenko, S. Bayramova, C. Garcia, I. Pak, Evgenia V Shrainer, E. Voronina, E. Sokolova, Michael Johnson, Richard Miller
Related Content
Claims (6)
People with a specific gene variation called PPARG may see much better results from taking omega-3 supplements—like lower bad cholesterol and triglycerides—than people without that gene variation.
For middle-aged and older adults with high 'bad' cholesterol and certain gene versions, taking 2000 mg of omega-3 fish oil every day for three months can lower their bad cholesterol and triglycerides more than a placebo — and their genes might make this effect stronger.
Taking 2000 mg of omega-3s daily for three months doesn’t change your good cholesterol, total cholesterol, or inflammation markers — so if it helps lower bad cholesterol and triglycerides, it’s not because it’s reducing overall inflammation or affecting all types of fats in your blood.
People with a specific gene variation and high 'bad' cholesterol tend to have even higher cholesterol levels than others, and their bodies might respond better to omega-3 supplements to help lower it.
Taking 2000 mg of omega-3 fish oil daily for three months doesn't lower a common marker of body inflammation called hsCRP, no matter what your genes say. So, if omega-3s help your cholesterol, it's probably not because they're calming down inflammation.
Taking omega-3 supplements may help slow down the buildup of fatty plaques in your arteries by lowering bad fats in your blood, preventing clots, and calming down inflammation in your blood vessels.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.